Table of Contents Author Guidelines Submit a Manuscript
Analytical Cellular Pathology
Volume 2017, Article ID 7190546, 8 pages
https://doi.org/10.1155/2017/7190546
Research Article

Different Cytokine and Chemokine Expression Patterns in Malignant Compared to Those in Nonmalignant Renal Cells

1Department of Urology, University Medicine Greifswald, Greifswald, Germany
2Department of Trauma, Reconstructive Surgery and Rehabilitation Medicine, University Medicine Greifswald, Greifswald, Germany
3Department of Gynaecology and Obstetrics, University Medicine Greifswald, Greifswald, Germany
4Department of Anatomy and Cell Biology, RWTH Aachen University, Aachen, Germany
5Department of Trauma and Orthopaedic Surgery, BG Klinikum Unfallkrankenhaus Berlin gGmbH, Berlin, Germany

Correspondence should be addressed to Matthias B. Stope; ed.dlawsfierg-inu@epots.saihttam

Received 12 April 2017; Revised 6 June 2017; Accepted 18 June 2017; Published 9 July 2017

Academic Editor: Monica Cantile

Copyright © 2017 Nadine Gelbrich et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. S. Parihar and H. S. G. R. Tunuguntla, “Role of chemokines in renal cell carcinoma,” Reviews in Urology, vol. 16, pp. 118–121, 2014. View at Google Scholar
  2. G. Low, G. Huang, W. Fu, Z. Moloo, and S. Girgis, “Review of renal cell carcinoma and its common subtypes in radiology,” World Journal of Radiology, vol. 8, no. 5, pp. 484–500, 2016. View at Google Scholar
  3. K. L. Reckamp, R. M. Strieter, and R. A. Figlin, “Chemokines as therapeutic targets in renal cell carcinoma,” Expert Review of Anticancer Therapy, vol. 8, no. 6, pp. 887–893, 2008. View at Google Scholar
  4. M. Lahn, P. Fisch, G. Köhler et al., “Pro-inflammatory and T cell inhibitory cytokines are secreted at high levels in tumor cell cultures of human renal cell carcinoma,” European Urology, vol. 35, no. 1, pp. 70–80, 1999. View at Google Scholar
  5. Q. Xu, M. Krause, A. Samoylenko, and S. Vainio, “Wnt signaling in renal cell carcinoma,” Cancers (Basel), vol. 8, no. 6, p. 57, 2016. View at Google Scholar
  6. V. Levina, B. M. Nolen, A. M. Marrangoni et al., “Role of eotaxin-1 signaling in ovarian cancer,” Clinical Cancer Research, vol. 15, no. 8, pp. 2647–2656, 2009. View at Google Scholar
  7. M. Mo, M. Zhou, L. Wang et al., “CCL21/CCR7 enhances the proliferation, migration, and invasion of human bladder cancer T24 cells,” PLoS One, vol. 10, no. 3, article e0119506, 2015. View at Google Scholar
  8. J. Mei and L. Liu, “Role of interleukin 17 in lung carcinogenesis and lung cancer progression,” Chinese Journal of Lung Cancer, vol. 19, no. 1, pp. 46–51, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Wu, P. Wu, Q. Huang, Y. Liu, J. Ye, and J. Huang, “Interleukin-17: a promoter in colorectal cancer progression,” Clinical and Developmental Immunology, vol. 2013, Article ID 436307, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Welte and X. H. F. Zhang, “Interleukin-17 could promote breast cancer progression at several stages of the disease,” Mediators of Inflammation, vol. 2015, Article ID 804347, 6 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. F. C. Zeng, M. Q. Zeng, L. Huang et al., “Downregulation of VEGFA inhibits proliferation, promotes apoptosis, and suppresses migration and invasion of renal clear cell carcinoma,” Journal of Onco Targets and Therapy, vol. 9, pp. 2131–2141, 2016. View at Google Scholar
  12. R. Lu, Z. Ji, X. Li et al., “Tumor suppressive microRNA-200a inhibits renal cell carcinoma development by directly targeting TGFB2,” Tumor Biology, vol. 36, no. 9, pp. 6691–6700, 2015. View at Google Scholar
  13. C. Dosquet, M. C. Coudert, E. Lepage, J. Cabane, and F. Richard, “Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?” Clinical Cancer Research, vol. 3, pp. 2451–2458, 1997. View at Google Scholar
  14. A. M. Krensky and Y. T. Ahn, “Mechanisms of disease: regulation of RANTES (CCL5) in renal disease,” Nature Clinical Practice Nephrology, vol. 3, no. 3, pp. 164–170, 2007. View at Google Scholar
  15. S. Lin, S. Wan, L. Sun et al., “Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia,” Cancer Science, vol. 103, no. 5, pp. 904–912, 2012. View at Google Scholar
  16. J. Banchereau, V. Pascual, and A. O’Garra, “From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines,” Nature Immunology, vol. 13, no. 10, pp. 925–931, 2012. View at Google Scholar
  17. V. Pelekanou, G. Notas, K. Theodoropoulou et al., “Detection of the TNFSF members BAFF, APRIL, TWEAK and their receptors in normal kidney and renal cell carcinomas,” Analytical Cellular Pathology (Amsterdam), vol. 34, no. 1-2, pp. 49–60, 2011. View at Google Scholar
  18. W. Yu, J. Chen, Y. Xiong, F. J. Pixley, Y. G. Yeung, and E. R. Stanley, “Macrophage proliferation is regulated through CSF-1 receptor tyrosines 544, 559, and 807,” The Journal of Biological Chemistry, vol. 287, no. 17, pp. 13694–13704, 2012. View at Google Scholar
  19. L. Yang, Q. Wu, L. Xu et al., “Increased expression of colony stimulating factor-1 is a predictor of poor prognosis in patients with clear-cell renal cell carcinoma,” BMC Cancer, vol. 15, p. 67, 2015. View at Google Scholar
  20. N. J. Kenney, H. B. Adkins, and M. Sanicola, “Nodal and Cripto-1: embryonic pattern formation genes involved in mammary gland development and tumorigenesis,” Journal of Mammary Gland Biology and Neoplasia, vol. 9, no. 2, pp. 133–144, 2004. View at Google Scholar
  21. L. Vallier, M. Alexander, and R. A. Pedersen, “Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells,” Journal of Cell Science, vol. 118, Part 19, pp. 4495–4509, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. M. G. Lawrence, N. V. Margaryan, D. Loessner et al., “Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells,” The Prostate, vol. 71, no. 11, pp. 1198–1209, 2011. View at Google Scholar
  23. I. Papageorgiou, P. K. Nicholls, F. Wang et al., “Expression of nodal signaling components in cycling human endometrium and in endometrial cancer,” Reproductive Biology and Endocrinology, vol. 7, p. 122, 2009. View at Google Scholar
  24. G. Liu, Y. J. Liu, W. J. Lian, Z. W. Zhao, T. Yi, and H. Y. Zhou, “Reduced BMP6 expression by DNA methylation contributes to EMT and drug resistance in breast cancer cells,” Oncology Reports, vol. 32, no. 2, pp. 581–588, 2014. View at Publisher · View at Google Scholar · View at Scopus